Top Markets
Coin of the day
Easywell Biomedicals, Inc. Easywell Biomedicals, Inc.

Easywell Biomedicals, Inc.

1799
Rank in Stocks #20891
Easywell Biomedicals, Inc., together with its subsidiaries, develops,... Easywell Biomedicals, Inc., together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients and over-the-counter drug products in America. It operates through Drug Development and Other segments. The company develops TLX-001, an anti-cough medicine; TLX-005, an anti-urinary incontinence medicine; TLX-006 for treatment of breast cancer in PMS women; TLX-007 and TLX-004, an anti-depressant; TLX-008 for prevention of pneumocystis pneumonia; TLX-012 for treatment of epilepsy; TLX-017 for treatment of chronic angina; TLX-011 for treatment of inflammatory lesions of rosacea; TLX-015 a prevention and treatment medicine for postpartum hemorrhage; TLX-018, a hemorrhage treatment drug; TLX-030, an anti-inflammatory medicine; TLX-47, an anti-inflammatory drug; and TLX-024, an anticonvulsant. It also develops TWB-201 for Parkinson patch; TLX-501, a urinary medicine; and TLX-502, a pneumonia medicine. In addition, the company provides thermometers, medical devices, and health food and products. It has a collaborative development agreement with Handa Pharmaceuticals and Handa Neuroscience, LLC for the development of TLX-050 for the treatment of neurological disorders. The company was formerly known as Actherm Inc. and changed its name to Easywell Biomedicals, Inc. in July 2015. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan.
Share Price
$0.96033064
Last synced: 2026-08-21
Market Cap
$119.74M
Change (1 day)
0.67%
Change (1 year)
-33.99%
Country
TW
Trade Easywell Biomedicals, Inc. (1799)

Category

Stock price history for Easywell Biomedicals, Inc. (1799)
Highest end of day price: $0.97 on 2026-08-01

Lowest end of day price: $1.30 on 2007-12-01
Stock price history of Easywell Biomedicals, Inc. from 2007 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 8.41%
2025 -43.99%
2024 51.85%
2023 149.09%
2022 -38.04%
2021 -6.91%
2020 92.67%
2019 -12.21%
2018 -38.93%
2017 -10.09%
2016 -35.63%
2015 -14.09%
2014 24.04%
2013 53.32%
2012 37.97%
2011 -49.82%
2010 -9.66%
2009 61.38%
2008 -30.93%
2007 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$61.28 68.71%
US
$51.38 67.85%
SE
$193.82 41.69%
FR
$120.88 71.87%
US
$62.69 1.96%
IT